FY2026 Earnings Forecast for XRN Issued By Huntington

Global Medical REIT Inc. (NYSE:XRN) – Stock analysts at Huntington issued their FY2026 earnings per share (EPS) estimates for Global Medical REIT in a research note issued to investors on Wednesday, November 4th. Huntington analyst R. Stevenson anticipates that the company will post earnings per share of $2.93 for the year. Huntington has a “Hold” rating on the stock. The consensus estimate for Global Medical REIT’s current full-year earnings is $2.66 per share. Huntington also issued estimates for Global Medical REIT’s Q4 2026 earnings at $0.51 EPS, Q1 2027 earnings at $0.52 EPS, Q2 2027 earnings at $0.56 EPS, Q3 2027 earnings at $0.59 EPS, Q4 2027 earnings at $0.62 EPS, FY2027 earnings at $2.28 EPS, Q1 2028 earnings at $0.63 EPS, Q2 2028 earnings at $0.66 EPS, Q3 2028 earnings at $0.68 EPS and FY2028 earnings at $2.67 EPS.

A number of other equities research analysts have also recently commented on XRN. Citizens Jmp lowered their target price on Global Medical REIT from $42.00 to $35.00 and set a “market outperform” rating on the stock in a research note on Wednesday. Wall Street Zen lowered shares of Global Medical REIT from a “hold” rating to a “sell” rating in a research report on Saturday, October 10th. Cantor Fitzgerald began coverage on shares of Global Medical REIT in a research report on Monday, September 21st. They set an “overweight” rating and a $43.00 price target for the company. Zacks Research upgraded shares of Global Medical REIT to a “hold” rating in a report on Wednesday, July 22nd. Finally, Weiss Ratings lowered shares of Global Medical REIT from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday. Two investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $38.60.

Global Medical REIT Trading Down 1.8%

Shares of Global Medical REIT stock opened at $26.49 on Friday. Global Medical REIT has a 1 year low of $26.19 and a 1 year high of $38.65. The firm has a market cap of $350.95 million, a PE ratio of 7.55 and a beta of 1.10. The stock has a fifty day moving average price of $32.78 and a 200-day moving average price of $35.13. The company has a debt-to-equity ratio of 1.44, a current ratio of 0.70 and a quick ratio of 0.59.

Global Medical REIT (NYSE:XRN) last posted its quarterly earnings data on Wednesday, November 4th. The company reported ($0.67) earnings per share for the quarter, missing the consensus estimate of $0.55 by ($1.22). The business had revenue of $40.34 million during the quarter. Global Medical REIT had a return on equity of 13.35% and a net margin of 36.80%.

Global Medical REIT Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Friday, December 18th. Shareholders of record on Friday, November 20th will be given a $0.16 dividend. This represents a $1.92 dividend on an annualized basis and a yield of 7.2%. The ex-dividend date of this dividend is Friday, November 20th. Global Medical REIT’s dividend payout ratio (DPR) is currently 54.86%.

Key Stories Impacting Global Medical REIT

These are some of the XRN stories that stood out recently:

• Positive Sentiment: Citizens JMP’s $35 target remains above the cited $26.49 share price, and the firm kept its market-outperform rating. Citizens JMP ratings
• Neutral Sentiment: Huntington’s forecasts call for $2.93 per share in FY2026, $2.28 in FY2027, and $2.67 in FY2028. The analyst also expects quarterly estimates to rise from $0.51 in Q4 2026 to $0.68 in Q3 2028, but maintained a Hold rating. These projections are not presented as a change to prior estimates. Global Medical REIT analyst estimates
• Negative Sentiment: Citizens JMP cut its price target from $42 to $35, a substantial reduction that may weigh on sentiment despite the retained outperform rating. Citizens JMP ratings

Global Medical REIT Company Profile

Global Medical REIT, Inc. is a healthcare-focused real estate investment trust that acquires and owns purpose-built medical facilities. It leases these properties to healthcare providers, including physician groups and health systems, that use them to deliver patient care. The company’s properties include medical office buildings, specialty hospitals, ambulatory surgery centers and inpatient rehabilitation facilities. Its leases are generally structured to provide long-term occupancy for tenants while supporting the company’s rental-income business.